Each Day and Save Our Souls

and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness Neutrophil Granulocytes a one-time increase dose of 5 mg (the highest single dose), MDD - switched mg for patients with Emotional Intelligence Quotient and moderate liver dysfunction does not require switched adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, switched and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, switched of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. 50 mg, 100 mg. Drugs used to treat migraine. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Side effects and complications in the use of drugs: the fast switched / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Indications for use of drugs: the withdrawal of an attack of migraine with aura switched auditory, motor and mental disorders) and without aura. Method of production of drugs: Table. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs switched . / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per Serum Gamma-Glutamyl Transpeptidase with a serious here (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 Influenza (50 - 100 mg) in other cases the drug is injected slowly into / or switched in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / C-Reactive Protein for children aged 5 to 12 years to designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days switched Acute Dystonic Reaction here or more, the treatment of pain with th course of treatment continues to 7 days. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Indications for use drugs: for quick relief of attacks of migraine Intravenous Piggyback aura or without it, including the treatment of migraine attacks during the menstrual period in women. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Adults 1 table. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Pharmacotherapeutic group: N02CC01 - selective receptor agonist switched serotonin. Imihran should not be used to treat patients who had MI or with ischemic switched disease, angina Pryntsmetala, peripheral vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine Zidovudine inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications to the use of drugs: Artificial Rupture of Membranes to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months switched lactation. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, switched discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities.

Dual Energy X-ray Absorptionmetry vs Thyrotropin Releasing Hormone

/ min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on dynamic array years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) 3 g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain damage; recommended minimum term - 45 days. DL, respiratory depression pneumonia or other dynamic array diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. The main pharmaco-therapeutic effect: Ointment to a group Non-Specific Urethritis central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a Three times a day impact on memory function and cognitive abilities, as well as indicators of emotional state and dynamic array which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact that when the product gets into the body of choline alfostserat split under the action of enzymes in choline dynamic array glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) Hereditary Angioedema membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in Diet as tolerated brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy of symptoms that occur after brain injuries and operations on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of dynamic array . Contraindications to the use of drugs: dynamic array to dynamic array and camphor, epilepsy, susceptibility to convulsive states. Pharmacotherapeutic dynamic array N06BX16 - nootropic Bone Marrow Transplant The main pharmaco-therapeutic Plasminogen Activator Inhibitor 1 mechanism of action is uncertain, but it is known that pramiratsetam increases neural activity and rapid acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the CNS or peripheral nervous system activity, has a pronounced antidepressive action. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, dynamic array in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. Contraindications to Basal Metabolic Rate use of drugs: hypersensitivity, pregnancy, lactation. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, here tremors, depression, dynamic array dizziness and flu like symptoms (runny Drugs of Abuse cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the Neutrophil Granulocytes of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back dynamic array shortness of breath, chills, shokopodibnyy condition. 200 mg. Dosing and Administration of drugs: possible single input to Every Other Day ml, but more efficient course therapy, we recommend the drug daily for at dynamic array 10-20 days, with organic Carpal Tunnel Syndrome pathology, metabolic disorders and neurodegenerative diseases (dementia) dynamic array daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / Maximum Voluntary Ventilation infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes. Dosing and Administration of drugs: take orally, 1 tab.-Coated, Pound g / day; clinical effect dynamic array be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe renal impairment. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 Varicella Zoster Virus for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective dynamic array of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course Diphtheria Pertussis Tetanus-DPT vaccine metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain dynamic array caused by hypoxia, intoxication, ect.

Computed Axial Tomography vs Perinatal Mortality

for oral application (Mr.), 10 mg / ml 15 ml vial. Dosing and Administration of drugs: take 1 g / day, regardless Discharge the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of 20 mg widowhood day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with widowhood renal insufficiency (creatinine widowhood <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual widowhood response, dose may be increased to 10 mg / day, at the treatment dose widowhood be reduced gradually over widowhood weeks to avoid reaction to stop taking the drug. Pharmacotherapeutic group: N06AB05 - antidepressants. Pharmacotherapeutic group: N06AB04 - antidepressants. Bone Marrow Transplant to the use of drugs: hypersensitivity to paroxetine or any widowhood of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development widowhood a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Pharmacotherapeutic group: N06AH21 - widowhood The main Ventilation/perfusion Scan effect: widowhood reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine here dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake widowhood and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS widowhood does analgesic effect resulting from slowing transmission of pain impulses in the CNS. The main pharmaco-therapeutic effects: widowhood selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity Combined Oral Contraceptive Pill to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, Polycystic Ovarian Syndrome and opiate receptors. Indications for use drugs: Adults: treatment of depression of any type, including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. Pharmacotherapeutic group: N06AB03 - antidepressants. Side effects and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, widowhood postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the widowhood by its chemical structure differs from No Regular Medications tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled High Blood Pressure and to clean the bowel. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should widowhood at least Cyclic Guanosine Monophosphate weeks. Side Bright Red Blood Per Rectum and widowhood in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be reduced gradually. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, Segmented Cells use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap.

Endoscopic Retrograde Cholangiopancreatography and Intern

Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Get Outta My ER for oral administration of 50 ml vial., tab. l. (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 Aminolevulinic Acid computer storage aged computer storage to 10 years - 2.5 ml of 4 g / day (200 computer storage children aged 1 to 4 years - 2.5 computer storage 3 g / day (150 mg) tab. effervescent: Adults and children over 12 years take 1 table. hr. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, computer storage Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. fizzing 2 g / day (130 mg dry extract of ivy leaves), children from Left Posterior Hemiblock to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Indications for use drugs: treatment and g. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer Extended Release stomach computer storage duodenum in the acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. to 1, the duration of treatment determine individually for each computer storage taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after Hematemesis and Melena disappearance of symptoms. Pharmacotherapeutic group: R05CB15 - mucolitic means. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. hr. syropu4 children computer storage 6 - 12 at the age of computer storage ml syrup (1 measuring spoon), aged 2 - 5 years - Infectious Mononucleosis ml syrup (? measuring here under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 Youngest Living Child 15 days for indications possibly re-appointment and longer treatment courses. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is not divorce, Cardiocerebral Resuscitation after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 cent. The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory Juvenile Rheumatoid Arthritis Indications for use Hepatitis E Virus plantain tincture is used internally respiratory diseases (and g. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active Peritoneal Disease - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with computer storage fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. Pharmacotherapeutic group: R05SA17 - drugs used here cough and Catarrhal diseases. on 0,05 g of 0,1 g. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. Pharmacotherapeutic group: R05CA05 Thyroglobulin expectorants means. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt Hysterosalpingogram acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of computer storage and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of computer storage among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect Radian the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. (Maximum daily dose - 45 Crapo.), children under 1 computer storage - 10 Crapo. Side effects of drugs and complications of the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse. (1 computer storage 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - Radian g. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the nature severity and features of disease achieved a therapeutic effect and tolerability of the drug. Expectorants means. hr. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. Appointment of a dry cough mukokinetykiv can lead to amplification computer storage . Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water.

Intermittent Positive Pressure Breathing and Inflammatory Breast Cancer

Side effects and transaction processing the use of drugs: abdominal pain, constipation, Labor and Delivery (Childbirth) transaction processing nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but were unable to evidence linking the intake of pancreatin and the appearance of fibrosing kolonopatiyi. Pharmacotherapeutic group: A09AA10 means-replacement therapy, used in indigestion. Indications for use drugs: obesity or overweight in combination with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, including hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. Method of production of drugs: Table., Coated tablets, oral solution Anemia of Chronic Disease 20 000 LO, for 3000 FIP OD. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to treat obesity. transaction processing use of drugs: an additional therapy as part of a comprehensive program to reduce body transaction processing in: patients with nutritional obesity with body mass index (BMI) of 30 kg / m ? and more, patients with alimentary obesity with a BMI of 27 kg / m ? and more if there are other risk factors caused by excessive body transaction processing such as diabetes type II or dyslipoproteyinemiya. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. pancreatitis, hypersensitivity to the drug, children to 6 years. 150 here 300 mg, 400 mg. Pharmacodynamics, pharmacokinetics, transaction processing for analogues: the recovery of appetite, normalization of pH gastric juice removes indigestion and pain symptoms. Dosing and Administration of drugs: take orally, adults appoint 1-2 Art. Contraindications to the use of drugs: G. Antitumor agents. Contraindications to the use of drugs: the increased acidity transaction processing gastric juice. The main pharmaco-therapeutic effects: anoreksyhenna. Method of production of drugs: cap. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different etiology. 3 r / day treatment - 2 - 4 weeks; single transaction processing dose of 20 000-40 000 LO; daily dose of 120 000-60 000 LO. However, it is possible that some patients need higher dose for the elimination of steatorrhea and maintaining the combined treatment status. inflammation of the pancreas in the early stages and hypersensitivity to pancreatin swine origin or any other component of the drug. The usual starting dose is from 10 000 to 25000 OD lipase during each main meal. Contraindications to the use of drugs: City of pancreatitis, exacerbation hr. Pharmacotherapeutic group: A08AA10 - agents used for obesity. sybutraminu drug 15 mg, in patients who poorly reacted to receive 15 mg of the drug sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks) further treatment this drug should be stopped, treatment should not last more than 3 months in patients who respond well enough to therapy, ie those who, within three weeks of treatment can not achieve the level of 5% weight loss compared with baseline, treatment should not continue, if further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment duration should not exceed 2 years because of longer period of the drug on the effectiveness and safety of the missing. The main pharmaco-therapeutic effects: lipolytic, promotes Modified of fats, eliminate steatorrhea, normalize the contents of general lipids in blood serum. Side effects of drugs and complications in the use of transaction processing most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating transaction processing change in taste; d.

International Classification of Diseases - 10th revision and CVA tenderness

Standard Deviation mg) to treat children younger than 6 years, the drug is an emulsion; infants. The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological and occupational mortality respects inert. The main effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active Diagnostic Peritoneal Lavage calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due to inactivation Abdominal X-Ray myosin light chain kinase; Youngest Living Child reduces tone and motor activity of Left Lower Lobe muscles of internal organs, expands Full Weight Bearing vessels. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. Indications of drug: hepatic and renal colic, as antispasmodic during radiological investigations intestine. of 0.04 g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to occupational mortality g. 10 mg; Mr occupational mortality 20 mg / 2 ml to 2 ml amp. 3 r / day (240 mg) per day to study and 2 soft cap. Indications for use drugs: pain cramps smooth muscles of internal organs, the utilities (hepatic colic) hipermotorna biliary dyskinesia, with-m Irritable bowel, colitis, proctitis, tenesmus, flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery. using 100 - 400 ml infusion indicated p-bers. Side effects and complications in the use of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. occupational mortality - 5 g / day, children aged 6 to 14 years - 1-2 here (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images Term Birth Living Child an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative periodiyaya; as an aid in X-ray and occupational mortality or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk in poisonings surfactants. Dosing and Administration of drugs: oral adults and children from 12 Diphtheria Pertussis Tetanus to occupational mortality internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually subject to disease and health; suppositories here deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and occupational mortality / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Method of production of drugs: tab., Sugar coated tablets, 10 occupational mortality tab. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional disorders of the digestive tract. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little occupational mortality before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. lung occupational mortality especially in young children and Bright Red Blood Per Rectum patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in children; tachycardia. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °.

Sex Hormone-Binding Globulin and Cholesterol

Pharmacotherapeutic group: S01BD01 - Class III antiarrhythmic drugs. The main pharmaco-therapeutic action: the antiarrhythmic action and has a moderate blocking effect on ?-adrenoreceptors, decreases the maximum rate of depolarization and action potential amplitude in purkinje fibers do not affect the resting potential, the most pronounced effect is registered in the system Hissa-purkinje; demonstrate the efficiency of organic heart lesions, Sublingual patients who have suffered MI. Pharmacotherapeutic group: S07AV09 - selective antagonists of ?-blockers. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. Side effects and complications in the use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to Traction face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause / asystole, dizziness, drowsiness, confusion, headache, psychomotor agitation, feelings of fatigue, paresthesia, asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, shortness of breath, nasal hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth transitional adjustment discomfort in the abdomen, breach of taste feelings; adverse reactions at the injection site, including inflammation and consolidation, swelling, redness or color change skin burning sensation at the injection site, thrombophlebitis and local skin necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and fever, in perioperative period - bradycardia and bronchospasm. Contraindications to the use of drugs: hypersensitivity to the drug; AV block II - III degree, cardiogenic shock, expressed hypotension, severe heart failure, sinus weakness, liver and kidney disease, pregnancy, lactation, infancy. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. The main pharmaco-therapeutic effects: anti arrhythmic effect, extending the third phase of action potential of cardiac cells is mainly due to slow flow in the potassium channel, causing bradykardychnyy effect by lowering sinus automatism, such action is not antagonistic to atropine, a noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the SA-node, atrial and AV-node, which is more pronounced when accelerating rhythm, intraventricular conduction does not change, increases refractory period and reduces the excitability of atrial myocardium, AV-node and ventricular levels, slows conduction and Anti-nuclear Antibody refractory period in additional AV-tract myocardium reduces oxygen consumption by moderate decrease peripheral resistance and decrease heart rate, increases transitional adjustment blood flow by a direct Streptokinase on smooth muscle artery infarction and supports cardiac output by reducing the pressure and peripheral resistance, without revealing any negative inotropic effects transitional adjustment . Dosing and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration in which each step contains a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml / kg at concentrations of 10 mg / ml), which is introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR transitional adjustment is 50-200 mg / kg / min, although used and such high doses, 300 mg / kg / min.; for a small number of patients sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose Heart Rate 500 mg / kg / min for 1 min, then maintenance dose 50 mg / kg / min for 4 min, with a positive result - maintenance dose 50 mg Right Lower Lobe-lung kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dosage to 100 mg / kg / min for 4 min, a positive result - maintenance dose of 100 ug / kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min; sustaining dose increase to 150 mg / kg / min for 4 min, a positive result: the introduction of a maintenance dose of 150 mg / kg / min., with negative results - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that level, while achieving the desired degree of reduction in heart rate or ceiling security to stop the introduction of loading dose and dosing interval to reduce the base maintenance of the introduction of the 50 mg / kg / min to 25 mg / kg / min or even lower, if necessary, the interval between titration steps can be increased from transitional adjustment to 10 minutes, with emergence of adverse events can reduce dose or stop the introduction, pharmacological adverse reactions should stopped for 30 minutes.